Search

everythinglearnresearchcommunity

for

Search:↓

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Post-COVID-19 hair loss can be treated effectively with therapies like light therapy, microneedling, and scalp massage.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Ayurveda, using herbs like ginger, garlic, and turmeric, can reduce chemo-radiotherapy side effects in cancer patients.

Females are more affected by immune-related skin diseases, needing targeted health interventions.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Early diagnosis of colorectal cancer in young patients with certain symptoms is crucial for better outcomes.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

B6J mice live longer before 24 months, but B6N mice live longer after; both strains show weight gain, increased food and water intake, and health issues as they age.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.